Archive for the ‘Injectables’ Category

Is Botox safe or is it toxic?

Monday, June 8th, 2009 by newseditor

A patient expressed concern about the toxicity of Botox and inquired about the way human bodies dispose of it.  I responded that, although technically speaking it is developed from the botulinum toxin, the product is not toxic. 

Cosmetic doses of Botox are very small and not considered to be in a “toxic” range. Plus, Botox is used for a variety of non-cosmetic purposes that require a much larger dose. When it was first used over a century ago, it was for non-cosmetic use. It has a remarkable safety profile and as far as I am aware, there are no toxicity concerns for cosmetic use.  After injection, the purified protein of Botox is rapidly broken down into its components and then reused or excreted in urine. The breakdown products are parts of your normal body molecules, which are nothing foreign.

 

Can Botox injection permanently fix frown lines?

Wednesday, June 3rd, 2009 by newseditor

One young patient complained to me about “very noticeable furrows” of the forehead”, asking if Botox could treat the condition and permanently stop the muscle action that caused it. I said that it could definitely help.

Botox will be very useful in paralyzing the muscles between your eyebrows. Those particular muscles are called ‘corrugators’ and they’re responsible for causing the angry-looking wrinkles in the ‘glabellar region’ between your brows. Botox will certainly minimize the condition; using it every 4-6 months will prevent muscle contraction and prevent your lines from getting deeper.

However, Botox is not the end-all solution to furrows: If a patient already has existing lines between the eyebrows when not frowning, Botox cannot remove the lines completely – only make them softer. There are possible treatment options to remove the lines completely; combining Botox with a dermal filler, or with laser treatment are two possibilities.

Patient Surveys Provide Insight On Botox, Wrinkle Fillers

Monday, June 1st, 2009 by newseditor

A group of researchers working with the American Society for Aesthetic Plastic Surgery (ASAPS) sent questionnaires last March to 687 patients who had received Botox and/or wrinkle filler treatment. 

The findings indicate that wrinkle treatments, such as Botox or Juvederm, are more ‘mainstream’ than people once thought. Some of those noteworthy findings are as follows:

 - Most survey respondents described themselves as healthy individuals.  95 percent of them reported exercising and 78 percent cited healthy eating habits.

 - Nearly 70 percent of the respondents who had been treated with Botox also opted for dermal filler treatment.

 - Who is the ‘typical’ patient?  According to the survey results, she’s “a married, working mother between 41-55 years of age with a household income of under $100,000.”

 - 66 percent of the respondents said they received Botox treatment 2-3 times per year.

 - 72 percent of the respondents chose Botox to treat glabellar lines – the vertical lines that appear between your eyebrows.  

 - 63 percent of the respondents chose dermal fillers to treat facial wrinkles and folds, mostly the nasolabial folds or ‘smile lines’ that travel from the nose to each side of the mouth. 

 - 87 percent reported that they discussed their treatments with others, and 70 percent said they received support from the people they told.

A full summary of the results is available (in MS Word) here.

FDA Approves Dysport for Muscle Spasms and Wrinkles

Sunday, May 3rd, 2009 by newseditor

The FDA gave its stamp of approval to Medicis pharmaceutical for the new Botox competitor, Dysport. Surgeons and dermatologists may have the drug available for cosmetic use in just 30 – 60 days.

Rather than rebranding the drug ‘Reloxin’ as planned, Medicis decided to retain its original European name, Dysport

Coinciding with the April 30th announcement was a 3 percent drop in Allergan’s (maker of Botox) shares, and a 14 percent increase of Medicis’ shares. Analysts and industry professionals expect Dysport to carry a slightly lower price tag than Botox, and say it could capture as much as 30 percent of the current market.

Botox and Dysport both perform the same basic function – neuromuscular blocking to relax and prevent wrinkles. Dysport however, is said to be more diluted than Botox and thus more cost effective for providers. The recent FDA approval of dysport also came with a unique warning label describing the risks associated with the botulinum toxin.

For more information on wrinkle treatments in California, see our homepage.

Alternative, Off-Label Uses for Botox are Still Being Found

Thursday, April 30th, 2009 by newseditor

For years now, surgeons have used Botox to smooth out facial wrinkles, but that purpose hasn’t been anywhere near the extent of the drug’s usage. Doctors once thought that off-label use of Botox – which was originally developed for treating muscles spasms – would be fairly limited. If you do a little research however, you’ll find that physicians are using Botox for a wide variety of new and interesting purposes.

Many doctors use Botox to treat headaches, and their basic procedures are hardly any different than those of wrinkle treatment. It isn’t entirely clear how the Botulinum toxin provides relief; it may work to inhibit certain pain-transmitting nerves. But evidently, many people suffer from fewer headaches after being treated with Botox.

As reported in the Journal of the American Academy of Dermatology, researchers from Allergan Inc. conducted surveys about sweating, revealing that almost 3 percent of the U.S. population (7.8 million people) believe their sweating to be excessive. At the time of the survey (in 2004), less than half of the respondents had sought medical help for the problem. Botox blocks the localized release of a specific chemical that stimulates sweating, and so the FDA approved it for this use years ago.

Last March, the New York Times published a story on the off-label use of Botox to help those who have suffered a stroke and have trouble relaxing certain muscles. According to the experts, “only about 5 percent of the stroke patients who could benefit from its use ever get it.”

Patients with even more obscure conditions have found success using Botox. In Feb 2008, USA Today reported that radio personality Diane Rehm (of National Public Radio) had received routine off-label Botox treatments for a vocal disorder called spasmodic dysphonia.

Aside from these therapies, surgeons and dermatologists are finding even more cosmetic uses for Botox. Dr. Lawrence Reed recently told an ABC news affiliate that “we’re at the tip of the iceberg where Botox is going to be used.” Reed has apparently been pioneering some interesting new cosmetic applications.

For acne, Dr. Reed injects Botox just below the skin: “It decreases the muscle pump and blocks the production of oils, so we use it for acne,” he claims. Other patients of Dr. Reed found success using Botox to relax certain muscles and actually make their eyes appear larger, and to supplement laser skin resurfacing.

A few words of caution: If you’re considering Botox for any off-label use, make sure you choose a qualified physician. Despite the optimism surrounding Botox as a ‘wonder drug’, there have been complications and side effects associated with off-label use and inexperienced providers.  For more information, see our Botox page, or contact Dr. Maddali for a consultation.

New Wrinkle Injection 'Reloxin' Awaits FDA Approval

Thursday, March 19th, 2009 by newseditor

The latest issue of Archives of Facial Plastic Surgery features a medical study on Reloxin, the new wrinkle-reducing, Botox alternative, marketed by Medicis Pharmaceutical.  The study evaluated the safety and performance of Reloxin for its use on moderate to severe forehead wrinkles (or glabeller lines).  The results of the study appear fairly optimistic.

FDA approval of Reloxin has not yet been granted for U.S. sales, but clearance is expected to come this year.  Reloxin is being introduced with the hope that it will be the first direct competitor to Botox, in a market that helped Allergan Inc. net $1.3 billion last year with the wrinkle relaxing drug.

A California dermatologist who was involved in the study commented to Bloomberg news, saying “the side effects are the same as Botox” and “many of our patients liked it even better.”

The active ingredients in Reloxin and Botox are very similar; they each contain a particular ‘botulinum toxin’ that has been proven to relax the muscles that cause wrinkles in the face.

While Reloxin has actually been sold overseas under the name ‘Dysport’ for about 15 years, Botox has still managed to claim over 80 percent of the worldwide market for the neurotoxin.  One market analyst speculates that “Reloxin may be priced 15 percent lower than Botox” which could allow it to take a significant share of that market.